| Patient | Muhammad Ali |
|---|---|
| Date of birth | 1972-01-17 |
| Identifiers | MRN HR-BX001-SYN; SSN (made up) 000-01-7724 |
| Document date | 2026-10-06 |
| Author | Celeste Moreau, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic preventive visit; no new complaints. [S]
Mr. Ali is a 54-year-old man with young-onset Parkinson's disease, diagnosed twelve years ago, who comes for his periodic preventive visit four weeks after his six-month Parkinson's disease review. He completed the health risk assessment before the visit. He takes carbidopa-levodopa one and a half tablets three times a day, 30 minutes before meals, with an alarm on his phone, and has missed no doses. He has had no falls, emergency visits, or hospital stays this year. He walks or rides a stationary bicycle and does his physical therapy balance exercises about 180 minutes a week, and practices his voice exercises daily. He has no new concerns. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 54 |
| Safety events | No falls, emergency visits, or hospital stays this year |
| Medicines | Carbidopa-levodopa on time with phone alarms; no over-the-counter medicines or supplements |
| Active conditions | Parkinson's disease, Hoehn and Yahr stage 2.5, without dyskinesia or wearing-off; soft speech, improved after speech therapy |
| Functional status | Independent in all activities of daily living; Timed Up and Go 11 seconds at the six-month review |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good |
| Psychosocial | Lives with his spouse; close family and friends; busy schedule of public and charitable appearances, which he enjoys |
| Tobacco | Never used tobacco |
| Alcohol and drugs | No alcohol (AUDIT-C 0); no other drug use |
| Physical activity | About 180 minutes a week of walking, stationary cycling, and balance exercises |
| Nutrition | Regular meals; takes levodopa 30 minutes before meals and spreads protein through the day |
| Sleep | About seven hours a night; no dream enactment; not sleepy in the daytime |
| Activities of daily living | Independent; buttoning and handwriting slow |
| Instrumental activities of daily living | Independent; staff help with travel arrangements |
| Home safety | Grab bars in the shower, night lights, no loose rugs; smoke detectors working |
| Falls | No falls this year |
| Hearing and vision | No hearing concern; small print slower to read; no eye examination on record in recent years |
| Safety | Wears a seat belt; drives only short local trips in daylight; no firearms in the home |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever, night sweats, or fatigue beyond his usual |
| Eyes | Negative | No eye pain or double vision |
| Ears, nose, mouth, and throat | Negative | No hearing loss, drooling, or trouble chewing or swallowing |
| Cardiovascular | Negative | No chest pain, palpitations, lightheadedness on standing, or ankle swelling |
| Respiratory | Negative | No cough or breathlessness; no choking with meals |
| Gastrointestinal | Negative | No constipation, nausea, heartburn, or blood in the stool |
| Genitourinary | Negative | No urinary urgency or nighttime urination beyond once |
| Musculoskeletal | Negative | No joint or back pain |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Positive | Known tremor and slowness, better since the levodopa increase; no freezing, dyskinesia, or wearing-off |
| Psychiatric | Negative | Mood good; no anxiety, hallucinations, or impulse-control problems; PHQ-2 score 0 |
| Endocrine | Negative | No heat or cold intolerance, thirst, or frequent urination |
| Hematologic | Negative | No easy bruising or bleeding |
13 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Carbidopa-levodopa 25/100 mg oral tablet, one tablet by mouth three times daily | One tablet by mouth three times daily, at about 7 a.m., noon, and 5 p.m. | Oral route | 2014-10-01 to 2026-03-10 | completed | S |
| Carbidopa-levodopa 25/100 mg oral tablet, one and a half tablets by mouth three times daily, 30 minutes before meals | One and a half tablets (levodopa 150 mg) by mouth three times daily, 30 minutes before meals | Oral route | 2026-03-10 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-06 | Body height | 191 | cm | S |
| 2026-10-06 | Body weight | 101.2 | kg | S |
| 2026-10-06 | Body mass index (BMI) [Ratio] | 27.7 | kg/m2 | S |
| 2026-10-06 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-10-06 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-10-06 | Heart rate | 70 | /min | S |
| 2026-10-06 | Respiratory rate | 14 | /min | S |
| 2026-10-06 | Body temperature | 36.7 | Cel | S |
| 2026-10-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-06 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-10-06 | Total score [AUDIT-C] | 0 | {score} | S | ||
| 2026-10-06 | Cholesterol [Mass/volume] in Serum or Plasma | 192 | mg/dL | <=200 mg/dL | Normal | S |
| 2026-10-06 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 50 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-10-06 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 118 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-10-06 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-10-06 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
Vital signs recorded on 2026-10-06; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Alert, humorous, and engaged; weight 101.2 kg, BMI 27.7 |
| Eyes | Pupils equal and reactive; reduced blink rate |
| Ears, nose, and throat | Canals and tympanic membranes normal; oropharynx clear; no pooling of saliva |
| Neck | No thyroid enlargement or nodes; no carotid bruits |
| Cardiovascular | Regular rhythm at 70 per minute; no murmur; no edema |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no masses or organ enlargement |
| Skin | No suspicious lesions |
| Neurological | Reduced facial expression; mild right-hand rest tremor; mild bradykinesia, better than in the spring; walks with good arm swing for him; no dyskinesia |
| Psychiatric | Euthymic; judgment and insight intact |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Parkinson's disease, young onset (diagnosed at 42), Hoehn and Yahr stage 2.5, without dyskinesia or motor fluctuations | active | confirmed | G20.A1 | S — Synthetic modern coding of the publicly disclosed diagnosis; the stage and the absence of motor complications are synthetic. |
| Hypokinetic dysarthria with soft speech due to Parkinson's disease | active | confirmed | R47.1 | S — Synthetic modern coding of the publicly reported speech difficulty; the severity is synthetic. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 124/78 mmHg |
| Cholesterol screening and statin decision | Completed today | Total cholesterol 192, HDL 50, LDL 118, triglycerides 120 mg/dL. Ten-year risk about 5 percent with no diabetes, hypertension, dyslipidemia, or smoking, so a statin is not recommended; repeat in five years |
| Diabetes screening | Completed today | HbA1c 5.4 percent; overweight adult aged 35 to 70; repeat in three years |
| Healthy weight and activity | Completed today | BMI 27.7; counseled to keep up 150 minutes or more of weekly exercise, which also helps his balance and gait |
| Colorectal cancer screening | Ordered | No prior screening on record. Options discussed; he chose a yearly fecal immunochemical test, and a kit was given today. A positive test needs colonoscopy |
| Prostate cancer screening | Not indicated | Shared decision-making about PSA testing is recommended from age 55; to be discussed next year |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never used tobacco |
| Depression screening | Completed today | PHQ-2 score 0; PHQ-9 3 at the first visit this year |
| Anxiety screening | Completed today | GAD-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 0 |
| Hepatitis C and HIV screening | Ordered | One-time screening recommended for all adults in these age ranges; no prior result on record; drawn with his consent today |
| Hepatitis B screening | Ordered | One-time triple panel recommended for all adults; drawn with today's blood tests |
| Influenza vaccine, this season | Completed today | Given today |
| Pneumococcal vaccine | Completed today | PCV20 given today; a single dose is recommended for adults 50 and older |
| Recombinant zoster vaccine | Completed today | Dose 1 given today; dose 2 due in two to six months |
| COVID-19 vaccine, this season | Due | Recommended; he will get it at the pharmacy next week |
| Tetanus, diphtheria, and pertussis booster | Due | No dose on record in the past ten years; to be given with the second zoster dose |
| RSV vaccine | Not indicated | Recommended at 75 and older, and from 50 with conditions that raise risk; his Parkinson's disease is not causing swallowing or breathing problems. Review yearly |
| Dental examination | Referred | No dental visit on record; Parkinson's disease calls for a dental examination every six months; appointment arranged |
| Eye examination | Due | No eye examination on record in recent years; a comprehensive eye examination advised |
| Falls prevention | Completed today | No falls; Timed Up and Go 11 seconds at the six-month review; exercise and home-safety measures continue |
Immunizations given today: Influenza vaccine, 2026-2027 season; Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]
Guideline basis: CMID: Clinical Monitoring Intelligence Database, Parkinson's disease monograph (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: Quarterly Parkinson's disease review in about two months. Second zoster dose and the Tdap booster in two to six months. Dental appointment arranged. Return the stool test kit within two weeks. Next preventive visit in one year. [S]
Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is staying active, keeping up his appearances and charitable work, and being told plainly about his health so he can take part in every decision. The discussion covered how Parkinson's disease can change over many years and why his wishes should be revisited as it does. He chose not to record specific treatment preferences today. The plan will be revisited yearly and at any change in stage. [S]